Prevalence and clinical aspects of depression in Parkinson's disease: A systematic review and meta-analysis of 129 studies

被引:100
作者
Cong, Shengri [1 ]
Xiang, Chunchen [1 ,2 ]
Zhang, Shun [1 ]
Zhang, Taiming [1 ]
Wang, Hailong [3 ]
Cong, Shuyan [1 ,4 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Neurol, Shenyang, Peoples R China
[2] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China
[3] China Med Univ, Hosp 1, Dept Clin Epidemiol & Evidence Based Med, Shenyang, Peoples R China
[4] China Med Univ, Shengjing Hosp, Dept Neurol, 36 Sanhao St, Shenyang 110004, Liaoning, Peoples R China
关键词
Depression; Meta-analysis; Prevalence; Review; Parkinson?s disease; SYMPTOMS; DEMENTIA; FATIGUE; ANXIETY; APATHY;
D O I
10.1016/j.neubiorev.2022.104749
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Depression is one of the most important non-motor symptoms in Parkinson's disease (PD), but its prevalence and related clinical characteristics are unclear. To this end, we performed a systematic review and meta-analysis based on 129 studies, including 38304 participants from 28 countries. Overall, the prevalence of depression in PD was 38 %. When compared with patients without depression, those with depression had a younger age of onset, a lower education level, longer disease duration, higher UPDRS-III, higher H&Y staging scale, and lower MMSE, SE-ADL scores. We observed that depression was associated with female patients, patients carrying the GBA1 mutation, freezing of gait (FOG), apathy, anxiety and fatigue. Our results suggest that depression is an independent, frequent non-motor symptom in PD, appearing in the early stage and persisting throughout the disease duration. In addition, several clinical characteristics and motor and non-motor symptoms appeared to be associated with depression and negatively impacted on quality of life.
引用
收藏
页数:7
相关论文
共 40 条
[1]   Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations [J].
Alcalay, Roy N. ;
Levy, Oren A. ;
Waters, Cheryl C. ;
Fahn, Stanley ;
Ford, Blair ;
Kuo, Sheng-Han ;
Mazzoni, Pietro ;
Pauciulo, Michael W. ;
Nichols, William C. ;
Gan-Or, Ziv ;
Rouleau, Guy A. ;
Chung, Wendy K. ;
Wolf, Pavlina ;
Oliva, Petra ;
Keutzer, Joan ;
Marder, Karen ;
Zhang, Xiaokui .
BRAIN, 2015, 138 :2648-2658
[2]   Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: A meta-analysis [J].
Baiano, Chiara ;
Barone, Paolo ;
Trojano, Luigi ;
Santangelo, Gabriella .
MOVEMENT DISORDERS, 2020, 35 (01) :45-54
[3]   Cross-national epidemiology of DSM-IV major depressive episode [J].
Bromet, Evelyn ;
Andrade, Laura Helena ;
Hwang, Irving ;
Sampson, Nancy A. ;
Alonso, Jordi ;
de Girolamo, Giovanni ;
de Graaf, Ron ;
Demyttenaere, Koen ;
Hu, Chiyi ;
Iwata, Noboru ;
Karam, Aimee N. ;
Kaur, Jagdish ;
Kostyuchenko, Stanislav ;
Lepine, Jean-Pierre ;
Levinson, Daphna ;
Matschinger, Herbert ;
Medina Mora, Maria Elena ;
Browne, Mark Oakley ;
Posada-Villa, Jose ;
Viana, Maria Carmen ;
Williams, David R. ;
Kessler, Ronald C. .
BMC MEDICINE, 2011, 9
[4]   A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD [J].
Castrioto, A. ;
Thobois, S. ;
Anheim, M. ;
Quesada, J. L. ;
Lhommee, E. ;
Klinger, H. ;
Bichon, A. ;
Schmitt, E. ;
Durif, F. ;
Azulay, J. P. ;
Houeto, J. L. ;
Longato, N. ;
Philipps, C. ;
Pelissier, P. ;
Broussolle, E. ;
Moro, E. ;
Tranchant, C. ;
Fraix, V. ;
Krack, P. .
NPJ PARKINSONS DISEASE, 2020, 6 (01)
[5]   Evaluating the Role ofSNCA,LRRK2, andGBAin Chinese Patients WithEarly-OnsetParkinson's Disease [J].
Chen, Yongping ;
Gu, Xiaojing ;
Ou, Ruwei ;
Zhang, Lingyu ;
Hou, Yanbing ;
Liu, Kuncheng ;
Cao, Bei ;
Wei, Qianqian ;
Li, Chunyu ;
Song, Wei ;
Zhao, Bi ;
Wu, Ying ;
Cheng, Jingqiu ;
Shang, Huifang .
MOVEMENT DISORDERS, 2020, 35 (11) :2046-2055
[6]   Survival and dementia in GBA-associated Parkinson's disease: The mutation matters [J].
Cilia, Roberto ;
Tunesi, Sara ;
Marotta, Giorgio ;
Cereda, Emanuele ;
Siri, Chiara ;
Tesei, Silvana ;
Zecchinelli, Anna L. ;
Canesi, Margherita ;
Mariani, Claudio B. ;
Meucci, Nicoletta ;
Sacilotto, Giorgio ;
Zini, Michela ;
Barichella, Michela ;
Magnani, Corrado ;
Duga, Stefano ;
Asselta, Rosanna ;
Solda, Giulia ;
Seresini, Agostino ;
Seia, Manuela ;
Pezzoli, Gianni ;
Goldwurm, Stefano .
ANNALS OF NEUROLOGY, 2016, 80 (05) :662-673
[7]   Prevalence and risk factors for depression and anxiety in Chinese patients with Parkinson disease [J].
Cui, Shi-Shuang ;
Du, Juan-Juan ;
Fu, Rao ;
Lin, Yi-Qi ;
Huang, Pei ;
He, Ya-Chao ;
Gao, Chao ;
Wang, Hua-Long ;
Chen, Sheng-Di .
BMC GERIATRICS, 2017, 17
[8]   Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial [J].
Devos, David ;
Moreau, Caroline ;
Maltete, David ;
Lefaucheur, Romain ;
Kreisler, Alexandre ;
Eusebio, Alexandre ;
Defer, Gilles ;
Ouk, Thavarak ;
Azulay, Jean-Philippe ;
Krystkowiak, Pierre ;
Witjas, Tatiana ;
Delliaux, Marie ;
Destee, Alain ;
Duhamel, Alain ;
Bordet, Regis ;
Defebvre, Luc ;
Dujardin, Kathy .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (06) :668-674
[9]   Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study [J].
Di Giuda, Daniela ;
Camardese, Giovanni ;
Bentivoglio, Anna Rita ;
Cocciolillo, Fabrizio ;
Guidubaldi, Arianna ;
Pucci, Lorella ;
Bruno, Isabella ;
Janiri, Luigi ;
Giordano, Alessandro ;
Fasano, Alfonso .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (12) :1937-1948
[10]   Cognitive impairment and dementia in Parkinson's disease: Practical issues and management [J].
Emre, Murat ;
Ford, Paul J. ;
Bilgic, Basar ;
Uc, Ergun Y. .
MOVEMENT DISORDERS, 2014, 29 (05) :663-672